- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beijing SL Pharmaceutical Co Ltd (002038)
Beijing SL Pharmaceutical Co Ltd stock price live, this page displays SZ 002038 stock exchange data. View the 002038 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beijing SL Pharmaceutical Co Ltd real time stock price chart below.
What Is the Beijing SL Pharmaceutical Co Ltd Stock Price Today?
The Beijing SL Pharmaceutical Co Ltd stock price today is 5.91.
What Is the Stock Symbol for Beijing SL Pharmaceutical Co Ltd?
The stock symbol for Beijing SL Pharmaceutical Co Ltd is "002038."
What Stock Exchange Does Beijing SL Pharmaceutical Co Ltd Trade On?
Beijing SL Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Beijing SL Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Beijing SL Pharmaceutical Co Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002038 quote. (ISIN: CNE000001L31)
What Is the Beijing SL Pharmaceutical Co Ltd Stock Price Today?
The Beijing SL Pharmaceutical Co Ltd stock price today is 5.91.
What Is the Stock Symbol for Beijing SL Pharmaceutical Co Ltd?
The stock symbol for Beijing SL Pharmaceutical Co Ltd is "002038."
What Stock Exchange Does Beijing SL Pharmaceutical Co Ltd Trade On?
Beijing SL Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Beijing SL Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Beijing SL Pharmaceutical Co Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002038 quote. (ISIN: CNE000001L31)
Shenzhen
Currency in CNY
5.91
+0.22(+3.87%)
Closed·
Fair Value
An estimate of a Sl Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.65
5.91
52 wk Range
4.81
9.40
002038 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Sl Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.655.91
52 wk Range
4.819.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
002038 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sl Pharm A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Apr 28, 2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
136.84M / --
Compare 002038 to Peers and Sector
Metrics to compare | 002038 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002038PeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.7x | 31.0x | −0.4x | |
PEG Ratio | 0.03 | −0.84 | 0.00 | |
Price/Book | 1.2x | 2.3x | 2.6x | |
Price / LTM Sales | 10.3x | 5.4x | 3.1x | |
Upside (Analyst Target) | - | 40.2% | 48.8% | |
Fair Value Upside | Unlock | 20.4% | 5.7% | Unlock |
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republic of China and internationally. The company’s finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; paclitaxel injection; docetaxel injection; thymopentin; vinorelbine tartrate injection; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; dispersible; ornidazole; voriconazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; filgrastim; recombinant human interleukin-11; and recombinant human interleukin-2 products. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Sl Pharm A (002038) Stock Price Today?
The Sl Pharm A stock price today is 5.91 CNY.
What Stock Exchange Does Sl Pharm A Trade On?
Sl Pharm A is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Sl Pharm A?
The stock symbol for Sl Pharm A is "002038."
What Is the Sl Pharm A Market Cap?
As of today, Sl Pharm A market cap is 6.07B CNY.
What Is Sl Pharm A's Earnings Per Share (TTM)?
The Sl Pharm A EPS (TTM) is -0.48.
From a Technical Analysis Perspective, Is 002038 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Sl Pharm A Stock Split?
Sl Pharm A has split 8 times.
How Many Employees Does Sl Pharm A Have?
Sl Pharm A has 901 employees.
What is the current trading status of Sl Pharm A (002038)?
As of Aug 09, 2026, Sl Pharm A (002038) is trading at a price of 5.91 CNY, with a previous close of 5.69 CNY. The stock has fluctuated within a day range of 5.65 CNY to 5.91 CNY, while its 52-week range spans from 4.81 CNY to 9.40 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.